CareRx (TSE:CRRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CareRx Corporation, a leading pharmacy services provider to seniors in Canada, has received Toronto Stock Exchange approval to renew its normal course issuer bid, allowing for the purchase and cancellation of up to 1.5 million shares. This bid, starting on September 7, 2024, represents about 2.5% of its outstanding shares and follows a previous bid where the company acquired shares at an average price of $2.13.
For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.